Restricted accessLetterFirst published online 2012-2
Comment on the article by Stauch et al. ‘Intrathecal IgM synthesis in paediatric MS is not a negative prognostic marker of disease progression: quantitative versus qualitative IgM analysis’
StauchCReiberHRauchenzaunerM. Intrathecal IgM synthesis in pediatric MS is not a negative prognostic marker of disease progression: Quantitative versus qualitative IgM analysis. Mult Scler J2011; 17: 327–334.
2.
VillarLMMasjuanJGonzalez-PorqueP. Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS. Neurology2002; 59: 555–559.
3.
AnderssonMAlvarez-CermeñoJCBernardiG. Cerebrospinal fluid in the diagnosis of multiple sclerosis: A consensus report. J Neurol Neurosurg Psychiatry1994; 57: 897–902.
4.
FreedmanMSThompsonEJDeisenhammerF. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: A consensus statement. Arch Neurol2005; 62: 865–870.
5.
PohlDRostasyKReiberHHanefeldF. CSF characteristics in early-onset multiple sclerosis: A tool for early diagnosis. Neurology2004; 63: 1966–1967.
6.
ReiberHTeutMPohlDRostasyKMHanefeldF. Pediatric multiple sclerosis: Age related differences and time course of the neuroimmunological response in CSF. Mult Scler J2009; 15: 1466–1480.
7.
KaiserRLückingCH. Intrathecal synthesis of IgM and IgA in neurological diseases: comparison of two formulae with isoelectric focusing. Clin Chim Acta1993; 216: 39–51.
8.
KaiserR. Affinity immunoblotting: rapid and sensitive detection of oligoclonal IgG, IgA and IgM in unconcentrated CSF by agarose isoelectrofocusing. J Neurol Sci1991; 103: 216–225.
9.
SindicCJMMonteynePLaterreEC. Occurrence of oligoclonal IgM bands in cerebrospinal fluid of neurological patients: an immunoaffinity-mediated capillary blot study. J Neurol Sci1994; 124: 215–219.
10.
SmithiesO. Disulfide-bond cleavage and formation in proteins. Science1965; 150: 1595–1598.
11.
SchneiderREulerBRauerS. Intrathecal IgM synthesis does not correlate with the risk of relapse in patients with a primary demyelinating event. Eur J Neurol2007; 14: 907–911.
12.
VillarLMGonzález-PorquéPMasjuanJ. Description of a sensitive and reproducible method for the detection of oligoclonal IgM bands. J Immunol Meth2001; 258: 151–155.
13.
VillarLMMasjuanJGonzalez-PorqueP. Intrathecal IgM Synthesis in neurologic diseases: Relationship with disability in MS. Neurology2002; 58: 824–826.
14.
VillarLMSádabaMCRoldánE. Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS. J Clin Invest2005; 115: 187–194.
15.
ThangarajhMGomez-RialJHedströmAK. Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis. Mult Scler J2008; 14: 1208–1213.
16.
BoscáIMagranerMJCoretF. The risk of relapse after a clinically isolated syndrome is related to the pattern of oligoclonal bands. J Neuroimmunol2010; 226: 143–146.
17.
MandrioliJSolaPBedinR. A multifactorial prognostic index in multiple sclerosis. Cerebrospinal fluid IgM oligoclonal bands and clinical features to predict the evolution of the disease. J Neurol2008; 255: 1023–1031.
